API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TW /
  3. 2103.TW

TSRC Corp (2103 TW) stock market data APIs

NT$23.55 0.05(0.2%) as of November 22, 2024
Price chart is built with Anychart

TSRC Corporation, together with its subsidiaries, engages in the manufacture, import, transport, and sale of various synthetic rubber and related products in Taiwan, China, the United States, Vietnam, Thailand, Germany, Indonesia, Japan, and internationally. The company operates through two segments: Synthetic Rubber and Non-Synthetic Rubber. The company offers ESBR rubber for use in automotive tires, shoe soles, conveyor belts, military caterpillar and tow trucks tracks, sports equipment, and toys; SSBR rubber for use in energy-saving, high performance, and all-season tires; BR rubber that is used in the production of plastic modification for HIPS and high-speed radial tires; and NBR rubber for use in oil hoses and seals, rollers, industrial gaskets, belts, shoe soles, rubber plastic foam sheets, and conveyor belts. It also provides styrene-butadiene-styrene, styrene-isoprene-styrene, and styrene-ethylene/butylene-styrene copolymers, as well as T-BLEND applied materials for use in advance shoe and foam materials, soft touch and gel products, and overmolding materials. The company was formerly known as Taiwan Synthetic Rubber Corporation and changed its name to TSRC Corporation in August 1999. TSRC Corporation was incorporated in 1973 and is headquartered in Kaohsiung, Taiwan.

TSRC Corp Financial Data Overview

23.5
23.55
-
23.65
23.5
20.7-25.6
19 280 M
16.6786
826 M
33 261 M
0.794
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '2103',
Type: 'Common Stock',
Name: 'TSRC Corp',
Exchange: 'TW',
CurrencyCode: 'TWD',
CurrencyName: 'New Taiwan Dollar',
CurrencySymbol: 'NT$',
CountryName: 'Taiwan',
CountryISO: 'TW',
OpenFigi: NULL,
ISIN: 'TW0002103009',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Basic Materials',
Industry: 'Specialty Chemicals',
}

TSRC Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 33 261 M
  • EBITDA 2 506 M
  • Earnings Per Share 1.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get TSRC Corp Earnings via APIs

  • Latest Release 2024-11-05
  • EPS/Forecast NaN

Get TSRC Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get TSRC Corp latest news via APIs

Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance

BARCELONA, Spain, May 9, 2022 /PRNewswire/ -- Good start to the year with Core Net Sales* at €218.8 MM (+1.6% year-on-year) driven by recently launched products and good performance of European Der...
  • ALMIRALL
  • COVIS PHARMA
  • EUROPEAN DERMATOLOGY
  • GROWTH DRIVERS
  • PERFORMANCE
  • POSITIVE IMPACT

Almirall: Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis

- Skin clearance and itch, key signs and symptoms of atopic dermatitis, were significantly improved with lebrikizumab treatment in combination with TCS BARCELONA, Spain, April 11, 2022 /PRNewswire/ -...
  • AD
  • ALMIRALL
  • ATOPIC DERMATITIS
  • LEBRIKIZUMAB
  • TCS
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com